| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA890: Difelikefalin for treating pruritus in people having haemodialysis |
|
Medicine details |
|
| Medicine name | difelikefalin (Kapruvia®) |
| Formulation | intravenous injection |
| Reference number | 3569 |
| Indication | Treatment of moderate-to-severe pruritus associated with chronic kidney disease in adult patients on haemodialysis. |
| Company | Vifor Fresenius Medical Care Renal Pharma UK Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Submission type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 24/03/2022 |
| NICE guidance | TA890: Difelikefalin for treating pruritus in people having haemodialysis |